SEC Form 4 · accession 0000914190-16-000956
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger C Lucas
Director
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 9, 2016 | S | 100 | $108.9248 | D | 3,929 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $101.19 | holding | — | — | — | — | Oct 26, 2026 | Common Stock | 3,985 | 3,985 | D |
| Stock Option (right to buy) | $91.78 | holding | — | — | — | Oct 30, 2014 | Oct 30, 2024 | Common Stock | 4,000 | 4,000 | D |
| Stock Option (right to buy) | $87.39 | holding | — | — | — | Oct 31, 2013 | Oct 30, 2023 | Common Stock | 4,000 | 4,000 | D |
| Stock Option (right to buy) | $87.34 | holding | — | — | — | Oct 29, 2016 | Oct 28, 2025 | Common Stock | 4,260 | 4,260 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016.
- F2The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.